Skip to main content
Clinical Trials/NL-OMON26456
NL-OMON26456
Not yet recruiting
Not Applicable

Multi-Interventional program for prevention and early Management of Anastomotic leakage after total mesorectal excision in Rectal cancer patIents, the IMARI-trial

Prof. dr. P.J. Tanis, Surgeon, Academic Medical Center, University of Amsterdam, the Netherlands0 sites488 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Prof. dr. P.J. Tanis, Surgeon, Academic Medical Center, University of Amsterdam, the Netherlands
Enrollment
488
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Prof. dr. P.J. Tanis, Surgeon, Academic Medical Center, University of Amsterdam, the Netherlands

Eligibility Criteria

Inclusion Criteria

  • 1\) Patients with a diagnosis of primary rectal cancer with the lower border below the level of the sigmoid take\-off on MRI, or regrowth in a watch and wait protocol, or undergoing completion/salvage surgery after local excision;
  • 2\) Age above 18;
  • 3\) Able to fill in questionnaires in Dutch and to come to out\-patient\-clinic visits;
  • 4\) Written informed consent.

Exclusion Criteria

  • 1\) Patients not undergoing resection with colo\-rectal/anal anastomosis;
  • 2\) Local recurrent rectal cancer;
  • 3\) Locally advanced rectal cancer requiring extended or multi\-visceral excision;
  • 4\) Synchronous colonic resections;

Outcomes

Primary Outcomes

Not specified

Similar Trials